Stock Events

Stock Events

Search...

MoonLake Immunotherapeutics (MLTX) Q4 2023 Earnings

29FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.33

-0.22

-0.11

0

Details

Expected EPS

-0.230425

Actual EPS

-0.12

Surprise EPS

0.11

Surprise Percent

+47.92%

Description

MoonLake Immunotherapeutics (MLTX) has reported earnings of -0.12 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.